Inactief instrument

Koers Actelion London S.E.

Aandelen

Duur

Periode

Stijl

Actelion : Pharmaceuticals US, Inc, - Results from Expert Delphi Consensus Survey on Treatment of Pulmonary Arterial Hypertension with Oral Prostacyclin Pathway Agents	06-04-20
Après Bioverativ, Sanofi s'empare de la biotech belge Ablynx pour 3,9 mrd EUR	29-01-18
Après Bioverativ, Sanofi rachète la biotech belge Ablynx pour 3,9 mrd EUR	29-01-18
Avec Bioverativ, Sanofi devient un leader mondial dans l'hémophilie	22-01-18
GNW-News: Cancellation of publicly held Actelion shares and delisting from SIX Swiss Exchange as of November 7, 2017	31-10-17

Sector

	Vaira. 1 jan.	Kapi.
VERTEX PHARMACEUTICALS INCORPORATED	+20,63%	127 mld.
ARGENX SE	+25,27%	27,67 mld.
BIONTECH SE	-20,17%	20,33 mld.
GENMAB A/S	-16,64%	16,79 mld.
BEIGENE, LTD.	-18,07%	15,63 mld.
WUXI APPTEC CO., LTD.	-47,70%	14,65 mld.
NEUROCRINE BIOSCIENCES, INC.	+11,92%	14,84 mld.
SAREPTA THERAPEUTICS, INC.	+58,32%	14,43 mld.
INSMED INCORPORATED	+149,98%	12,49 mld.